** Shares of Immuron IMC.AX rise 11.7% to A$0.067
** Stock set for its strongest session since January 14, if current trend holds
** The biopharmaceutical co says it has exceeded full-year sales of A$5 million ($3.08 million) for its Travelan drug, marking the co's highest annual sales
** About 437,320 shares change hands, 4.2x the 30-day average of 103,595 shares
** Stock down 15.2% YTD, including current session's moves
($1 = 1.6215 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。